Reply
1989; Wiley; Volume: 25; Issue: 6 Linguagem: Inglês
10.1002/ana.410250620
ISSN1531-8249
AutoresM. Maral Mouradian, J. L. Juncos, Giovanni Fabbrini, Thomas N. Chase,
Tópico(s)Neurological diseases and metabolism
ResumoAnnals of NeurologyVolume 25, Issue 6 p. 633-634 Letter Reply M. M. Mouradian MD, M. M. Mouradian MD Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke Bethesda, MDSearch for more papers by this authorJ. L. Juncos MD, J. L. Juncos MD Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke Bethesda, MDSearch for more papers by this authorG. Fabbrini MD, G. Fabbrini MD Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke Bethesda, MDSearch for more papers by this authorT. N. Chase MD, T. N. Chase MD Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke Bethesda, MDSearch for more papers by this author M. M. Mouradian MD, M. M. Mouradian MD Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke Bethesda, MDSearch for more papers by this authorJ. L. Juncos MD, J. L. Juncos MD Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke Bethesda, MDSearch for more papers by this authorG. Fabbrini MD, G. Fabbrini MD Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke Bethesda, MDSearch for more papers by this authorT. N. Chase MD, T. N. Chase MD Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke Bethesda, MDSearch for more papers by this author First published: June 1989 https://doi.org/10.1002/ana.410250620Citations: 9AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Mouradian MM, Juncos JL, Fabbrini G, Chase TN. Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies. Ann Neurol 1987; 22: 475–479 2 Juncos JL, Mouradian MM, Fabbrini G, et al. Levodopa methylester treatment of Parkinson's disease. Neurology 1987; 37: 1242–1245 3 Fabbrini G, Mouradian MM, Juncos JL, et al. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, part I. Ann Neurol 1988; 24: 366–371 4 Fabbrini G, Juncos JL, Mourdian MM, et al. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease. Ann Neurol 1987; 21: 370–376 5 Mouradian MM, Juncos JL, Fabbrini G, et al. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, part II. Ann Neurol 1988; 24: 372–378 Citing Literature Volume25, Issue6June 1989Pages 633-634 ReferencesRelatedInformation
Referência(s)